Hong Kong start-up Prenetics to list in the U.S. through $1.7 billion SPAC deal

Hong Kong biotech company Prenetics is going public through a merger with Artisan Acquisition — a SPAC backed by Adrian Cheng, CEO of New World Development.

from Health and Science https://ift.tt/39atG7F
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH